Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Simulation Market, By Products & Services
7.1. Medical Simulation Market, by Products & Services, 2021-2030
7.1.1. Healthcare Anatomical Models
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Web Based Simulators
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Healthcare Simulation Software
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Simulation Training Services
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Medical Simulation Market, By End-use
8.1. Medical Simulation Market, by End-use, 2021-2030
8.1.1. Academic Institutes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Military Organization
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Research
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Simulation Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.1.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.2.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Products & Services (2017-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 10. Company Profiles
10.1. Canadian Aviation Electronics, Ltd
10.1.1. Company Overview
10.1.2. Products & Services Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Laerdal Medical AS
10.2.1. Company Overview
10.2.2. Products & Services Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Kyoto Kagaku Co, Ltd
10.3.1. Company Overview
10.3.2. Products & Services Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Limbs & Things, Ltd.
10.4.1. Company Overview
10.4.2. Products & Services Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Mentice AB
10.5.1. Company Overview
10.5.2. Products & Services Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Simulab Corporation
10.6.1. Company Overview
10.6.2. Products & Services Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Simulaids, Inc
10.7.1. Company Overview
10.7.2. Products & Services Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Gaumard Scientific Company
10.8.1. Company Overview
10.8.2. Products & Services Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. 3D Systems
10.9.1. Company Overview
10.9.2. Products & Services Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Surgical Science Sweden AB
10.10.1. Company Overview
10.10.2. Products & Services Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms